No, I’m not. You’re citing notorious disinformation sites whose anonymous creators are relying on you seeing big numbers and not noticing the problems with methodology and analysis. When actual experts look at those studies, the results have not held up.
https://ebm.bmj.com/content/early/2021/05/26/bmjebm-2021-111...
> Different websites (such as https://ivmmeta.com/, https://c19ivermectin.com/, https://tratamientotemprano.org/estudios-ivermectina/, among others) have conducted meta-analyses with ivermectin studies, showing unpublished colourful forest plots which rapidly gained public acknowledgement and were disseminated via social media, without following any methodological or report guidelines. These websites do not include protocol registration with methods, search strategies, inclusion criteria, quality assessment of the included studies nor the certainty of the evidence of the pooled estimates. Prospective registration of systematic reviews with or without meta-analysis protocols is a key feature for providing transparency in the review process and ensuring protection against reporting biases, by revealing differences between the methods or outcomes reported in the published review and those planned in the registered protocol. These websites show pooled estimates suggesting significant benefits with ivermectin, which has resulted in confusion for clinicians, patients and even decision-makers. This is usually a problem when performing meta-analyses which are not based in rigorous systematic reviews, often leading to spread spurious or fallacious findings.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050401
> Meta-analysis/observational studies (https://ivmmeta.com) are circulating in the scientific community and over the Internet, demonstrating the efficacy of IVM during the pandemic. However, most of the listed references fail to provide adequate methodologies, making them difficult to be validated. Major limitations include, small sample sizes, doses and frequency of IVM use, open-label studies, in which neither the participants nor the investigators were blinded to the treatments, the use of concomitant medications in addition to IVM, assuming that the efficacy resulted from IVM (https://www.covid19treatmentguidelines.nih.gov/antiviral-the...).